Navigation Links
Study identifies growth factor essential to the most common malignant pediatric brain tumor
Date:2/28/2013

A multi-institutional team led by Massachusetts General Hospital (MGH) researchers has identified a molecular pathway that appears to be essential for the growth and spread of medulloblastoma, the most common malignant brain tumor in children. In their report in the Feb. 28 issue of Cell, they show that blocking this pathway which involves interactions between tumor cells and the surrounding tissues leads to regression of all four molecular subtypes of medulloblastoma in several mouse models.

"Our finding that a pathway carrying signals from host cells to tumor cells via placental growth factor and its receptor neuropilin 1 is critical to the growth of medulloblastoma, regardless of molecular subtype, strongly supports evaluating antibodies against these proteins as a novel therapeutic approach to this pediatric cancer," says Rakesh K. Jain, PhD, director of the Steele Laboratory for Tumor Biology at MGH and corresponding author of the study.

A highly malignant tumor that originates in the cerebellum, medulloblastoma accounts for about 20 percent of all pediatric brain tumors and is ten times more common in children than in adults. While aggressive treatment with surgery, chemotherapy and radiation significantly improves patient survival, those treatments can have long-term developmental, behavioral, and neurological side effects, particularly in the youngest patients, making the need for less damaging therapies essential.

Impetus for the current investigation began with studies by Peter Carmeliet, MD, PhD, of the Vesalius Research Center in Belgium, a co-author of the current study. Carmeliet found that an antibody against placental growth factor (PlGF) could block angiogenesis in a number of adult tumors. Since PlGF, unlike other angiogenic proteins, is not required for normal postnatal development, Jain and his Steele Lab colleague Lei Xu, MD, PhD, proposed targeting PlGF as anti-angiogenic treatment for pediatric t
'/>"/>

Contact: Katie Marquedant
kmarquedant@partners.org
617-726-0337
Massachusetts General Hospital
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Study finds diabetes does not increase risk of total knee surgical complications
2. Too Much Sitting Could Court Diabetes, Study Finds
3. UCLA study could explain why some people get zits and others dont
4. Babies Born to Obese Women Show Thicker Arteries: Study
5. Siblings Death May Boost Your Own Risk of Dying From Heart Attack: Study
6. Costs of ER Visits Vary in U.S., Study Finds
7. Einstein receives $3 million to study impact of soccer heading on the brain
8. Retailers should re-size maternity wear for women throughout their pregnancies, MU study finds
9. More Younger Women Diagnosed With Advanced Breast Cancer: Study
10. Dog Study Raises Prospect of Biological Pacemaker for Humans
11. Surgery and radiation improve survival for metastatic gastric cancer patients, Moffitt study shows
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study identifies growth factor essential to the most common malignant pediatric brain tumor
(Date:4/1/2015)... (PRWEB) April 01, 2015 IQ Formulations ... health and nutritional supplement companies in the U.S., today is ... testing and quality control standards for its herbal supplements.* GNC ... supply chain to ensure the accuracy of labeling on its ... veteran and IQ Formulations CEO Jay Cohen said: ...
(Date:4/1/2015)... April 01, 2015 Dr. Rod ... Distinguished Teaching Professor of the Department of Plastic Surgery ... doctors to review reports of blindness resulting from the ... . The group published their study, along with ideas ... Surgery journal. , "We began to see increasing reports ...
(Date:4/1/2015)... Senior Helpers of Central Texas ... of Choice Award by Home Care Pulse. The Best of ... to home care providers who receive the highest satisfaction scores ... in home care. This recognition reassures you that your home ... you with quality, trustworthy in home care. , In order ...
(Date:4/1/2015)... SkillSurvey, the leading provider of hiring ... and the premiere provider of on-line automated reference checking ... webinar on “Using Big Data to Recruit Millennials.” The ... officer of MorseLife, a nationally recognized provider of health ... families in Palm Beach County. , “As the most ...
(Date:4/1/2015)... The U.S. Department of Health and ... patients who are waiting for a lifesaving organ transplant.” ... statistic. , In the “Play Through with ... PGA TOUR golfer and two-time heart transplant recipient, raises ... organ donors. He inspires viewers by reminding them, ...
Breaking Medicine News(10 mins):Health News:IQ Formulations Applauds GNC for Enhancing Its Testing and Quality Control Processes for Herbal Supplements 2Health News:Dr. Rod J. Rohrich and Colleagues Study Rare Occurrences of Blindness Caused by Use of Facial Fillers 2Health News:Dr. Rod J. Rohrich and Colleagues Study Rare Occurrences of Blindness Caused by Use of Facial Fillers 3Health News:Senior Helpers of Central Texas Awarded Prestigious 2015 Senior Home Care Provider of Choice Award from Home Care Pulse 2Health News:SkillSurvey Hiring Expert Series Continues with Webinar Featuring MorseLife 2Health News:SkillSurvey Hiring Expert Series Continues with Webinar Featuring MorseLife 3Health News:Donate Life America and Genentech have Partnered to Develop the “Play Through with Erik Compton to Donate Life" Public Service Announcement 2
... The United States,Agency for International Development (USAID) is ... solution that reduces the risk of,diarrhea. Sur,Eau is ... chlorine solution can be added to water immediately ... principally young children and,people living with HIV and ...
... April 25 Torchmark,Corporation (NYSE: TMK ) announced ... of $.14 per share on all of the outstanding ... the close of business of the,Company,s transfer agent on ... 1, 2008., Torchmark Corporation is a holding company ...
... April 25 AMDL, Inc. (Amex:,ADL), an international ... and diagnostic products in China, announced,today that a ... AMDL has been posted,by analyst Lauren Rudd at ... price of $23 and a Buy Recommendation., ...
... G.,Rendell said national "Cover the Uninsured Week" is the ... Basic Care (PA ABC), which,passed the House of Representatives ... care to hundreds of thousands of uninsured,Pennsylvanians., "Cover ... "Every day we hear from Pennsylvanians who are ...
... TV Game Show Host Spark Controversy, LOS ANGELES, ... television game show "The Price Is Right," recently spoke ... group formed to,support responsible dog ownership. The group has ... went into effect this month in Los,Angeles County (isn,t ...
... eye surgery, but complaints show it may not be for ... Tiger Woods lauds vision-correcting LASIK surgery as "life changing." NASA ... military says it has been performed on 112,500 military personnel, ... and complications of this elective surgery being lost in this ...
Cached Medicine News:Health News:Disinfecting Water Saves Lives in Rwanda 2Health News:The Rudd Report, Dated April 18, 2008, Updates AMDL's Recent Achievements 2Health News:Governor Rendell Says 'Cover the Uninsured Week' is Perfect Time for Action on Program to Provide Access to Health Care for Uninsured 2Health News:Governor Rendell Says 'Cover the Uninsured Week' is Perfect Time for Action on Program to Provide Access to Health Care for Uninsured 3Health News:Governor Rendell Says 'Cover the Uninsured Week' is Perfect Time for Action on Program to Provide Access to Health Care for Uninsured 4Health News:Governor Rendell Says 'Cover the Uninsured Week' is Perfect Time for Action on Program to Provide Access to Health Care for Uninsured 5Health News:Governor Rendell Says 'Cover the Uninsured Week' is Perfect Time for Action on Program to Provide Access to Health Care for Uninsured 6Health News:Bob Barker's 'Right' to Free Speech Comes with a 'Price' 2Health News:FDA Examines 'Quality of Life' for LASIK Patients 2Health News:FDA Examines 'Quality of Life' for LASIK Patients 3
(Date:4/1/2015)... 2015  Egalet Corporation (Nasdaq: EGLT ) ... on developing, manufacturing and marketing innovative pain treatments, ... $60.0 million aggregate principal amount of its convertible ... private placement to qualified institutional buyers pursuant to ... as amended (the "Act"). Egalet also granted the ...
(Date:4/1/2015)... April 1, 2015  Salix Pharmaceuticals, Ltd. ("Salix"), ... Inc. (NYSE: VRX ) (TSX:VRX), today announced ... $750,000,000 aggregate principal amount of its 6.00% Senior ... " Notes ") pursuant to two redemptions. On ... principal amount of the Notes, and on May ...
(Date:4/1/2015)... AVIV, Israel , April 1, 2015 /PRNewswire/ ... a clinical-stage biopharmaceutical company focused on the development ... the treatment of liver diseases and cholesterol gallstones, ... Tonelli as Vice President of Clinical Operations. ... progressive experience in clinical operations, development and regulatory ...
Breaking Medicine Technology:Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 2Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 3Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 4Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 5Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 6Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 7Redemption of All of Salix's Outstanding 6.00% Senior Notes due 2021 2Redemption of All of Salix's Outstanding 6.00% Senior Notes due 2021 3Galmed Pharmaceuticals Announces the Appointment of George Tonelli as Vice President of Clinical Operations 2Galmed Pharmaceuticals Announces the Appointment of George Tonelli as Vice President of Clinical Operations 3
... blood ... flow, muscle oxygen supply, HOBOKEN, N.J., Oct. 17 ... reveals Pycnogenol(R),(pic-noj-en-all), an antioxidant plant extract from the bark of the ... which leads to an increase in blood flow and oxygen supply,to ...
... vs. Drug-Eluting and Bare ... ... TRIAS (TRI-stent Adjudication Study) trial of OrbusNeich,s,Genous Bio-engineered R stent has ... to Robbert de Winter, M.D., Ph.D.,principal investigator and director of the ...
Cached Medicine Technology:New Study: Pine Bark Extract Boosts Nitric Oxide (NO) Production 2New Study: Pine Bark Extract Boosts Nitric Oxide (NO) Production 3Enrollment Reaches 110 Patients in Investigator Initiated, Randomized Trial of OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) 2
Liquichek Immunology Control is a trilevel, liquid, comprehensive serum protein control with assayed values for a wide number of methods....
The Acceava pregnancy urine dipstick test provides qualitative determination of human chorionic gonadatropin in urine for early detection of pregnancy....
Invacare 5 Oxygen Concentrator, 230 VAC - Intl....
... The Invacare Platinum XL Concentrator offers all the ... Life to help lower lifecycle costs. Platinum XL ... before preventative maintenance is required by 40%! Platinum ... now a full 5 years with no hour ...
Medicine Products: